3-丙基水杨醛 | 83816-53-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-丙基水杨醛
• 中文别名: 2-羟基-3-丙基苯甲醛
• 英文名称: 2-hydroxy-3-propylbenzaldehyde
• 英文别名: 3-propyl-2-hydroxybenzaldehyde；3-propylsalicylaldehyde；3-n-propyl-2-hydroxybenzaldehyde
• CAS: 83816-53-9
• 化学式: C₁₀H₁₂O₂
• 分子量: 164.204
• InChiKey: BXHJYWXFFYWVIB-UHFFFAOYSA-N

物化性质

• 沸点：
  243℃
• 密度：
  1.103
• 闪点：
  100℃

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-丙基水杨醛 在 溴 作用下， 以 二氯甲烷 为溶剂， 以2.4 g的产率得到5-Bromo-2-hydroxy-3-propylbenzaldehyde
  参考文献：
  名称：

  POLYMERIZABLE COMPOUND AND OPTICAL ISOMER

  摘要：

  本发明提供了一种聚合物化合物，具有高储存稳定性，添加到聚合物化合物时不会导致结晶沉淀。本发明还提供了含有该化合物的聚合物化合物。当通过聚合物化合物的聚合产生薄膜状聚合物时，若用紫外光照射，它几乎不会变色或脱落。此外，本发明提供了通过聚合物化合物的聚合产生的聚合物，以及使用该聚合物的光学各向异性体。

  公开号：

  US20180022716A1
• 作为产物：
  描述：

  邻丙烯基氧基苯甲醛 在 二苯硫醚 、 5%-palladium/activated carbon 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 生成 3-丙基水杨醛
  参考文献：
  名称：

  Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics

  摘要：

  Procaspase-activating compound 1 (PAC-1) is an o-hydroxy-N-acylhydrazone that induces apoptosis in cancer cells by chelation of labile inhibitory zinc from procaspase-3. PAC-1 has been assessed in a wide variety of cell culture experiments and in vivo models of cancer, with promising results, and a phase 1 clinical trial in cancer patients has been initiated (NCT02355535). For certain applications, however, the in vivo half-life of PAC-1 could be limiting. Thus, with the goal of developing a compound with enhanced metabolic stability, a series of PAC-1 analogues were designed containing modifications that systematically block sites of metabolic vulnerability. Evaluation of the library of compounds identified four potentially superior candidates with comparable anticancer activity in cell culture, enhanced metabolic stability in liver microsomes, and improved tolerability in mice. In head-to-head experiments with PAC-1, pharmacokinetic evaluation in mice demonstrated extended elimination half-lives and greater area under the curve values for each of the four compounds, suggesting them as promising candidates for further development.

  DOI：

  10.1021/acs.jmedchem.5b00413

文献信息

• Cobalt–Nitrenoid Insertion-Mediated Amidative Carbon Rearrangement via Alkyl-Walking on Arenes
  作者：Jeonghyo Lee、Bora Kang、Dongwook Kim、Jia Lee、Sukbok Chang

  DOI：10.1021/jacs.1c10138

  日期：2021.11.10

  disclose the Cp*Co(III)(LX)-catalyzed amidative alkyl migration using 2,6-disubstituted phenyl azidoformates. Upon the cobalt–nitrenoid insertion toward the substituted ortho carbon, an arenium cationic species bearing a quaternary carbon is generated, and a subsequent alkyl migration process is suggested to occur through an unforeseen alkyl-walking mechanism. A quinolinol ligand of the cobalt catalyst system

  我们在此公开了使用 2,6-二取代苯基叠氮甲酸酯的 Cp*Co(III)(LX) 催化的酰胺化烷基迁移。在钴-硝基氮向取代的邻位碳插入后，会产生带有季碳的芳鎓阳离子物质，随后的烷基迁移过程被认为是通过不可预见的烷基行走机制发生的。提出了钴催化剂体系的喹啉醇配体，通过作为内部碱促进最终产物释放的重芳构化过程。这种新的机制模式使[1,2]-和[1,4]-烷基重排成为可能，从而允许N-杂环化合物的结构变化。
• Benzoxazepinones and their use as squalene synthase inhibitors
  申请人：——

  公开号：US20030078251A1

  公开（公告）日：2003-04-24

  There is disclosed a compound represented by the formula [I]: 1 wherein R 1 is optionally substituted 1-carboxyethyl group, optionally substituted alkyl-sulfonyl group, optionally substituted (carboxy-cycloalkyl)-alkyl group, —X 1 —X 2 —Ar—X 3 —X 4 —COOH (wherein X 1 and X 4 are a bond or alkylene group, X 2 and X 3 are a bond, —O—, —S—, Ar is divalent aromatic group etc.), R 2 is alkyl group optionally substituted with alkanoyloxy group and/or hydroxy group, R 3 is alkyl group, and W is halogen atom, etc., or a salt thereof. The compound has the cholesterol lowering activity and the triglyceride lowering activity and is useful for preventing and/or treating hyperlipidemia.

  披露了一种由公式[I]表示的化合物： 1 其中R 1 是可选地取代的1-羧乙基，可选地取代的烷基亚磺酰基，可选地取代的(羧基环烷基)-烷基，—X 1 —X 2 —Ar—X 3 —X 4 —COOH(其中X 1 和X 4 是键或亚烷基，X 2 和X 3 是键，—O—，—S—，Ar是二价芳香族等)，R 2 是可选地由酰氧基和/或羟基取代的烷基，R 3 是烷基，W是卤素原子等，或其盐。该化合物具有降低胆固醇活性和降低甘油三酯活性，用于预防或治疗高脂血症。
• [EN] ENZYME-ACTIVATING COMPOUNDS AND COMPOSITIONS<br/>[FR] COMPOSÉS ET COMPOSITIONS ACTIVANT DES ENZYMES
  申请人：HERGENROTHER PAUL J

  公开号：WO2014022858A1

  公开（公告）日：2014-02-06

  The invention provides compounds and compositions useful for the modulation of certain enzymes. The compounds and compositions can induce of cell death, particularly cancer cell death. The invention also provides methods for the synthesis and use of the compounds and compositions, including the use of compounds and compositions in therapy for the treatment of cancer and selective induction of apoptosis in cells.

  这项发明提供了用于调节某些酶的化合物和组合物。这些化合物和组合物可以诱导细胞死亡，特别是癌细胞死亡。该发明还提供了合成和使用这些化合物和组合物的方法，包括在治疗癌症和选择性诱导细胞凋亡中使用这些化合物和组合物的方法。
• Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids
  作者：Richard M. Keenan、Joseph Weinstock、Joseph A. Finkelstein、Robert G. Franz、Dimitri E. Gaitanopoulos、Gerald R. Girard、David T. Hill、Tina M. Morgan、James M. Samanen

  DOI：10.1021/jm00065a011

  日期：1993.6

  studies of these potent antagonists revealed that the thienyl ring, the (E)-acrylic acid, and the imidazole ring in addition to the two acid groups were important for high potency. Also, overlay comparisons of the parent diacid with both angiotensin II and a representative biphenylyltetrazole nonpeptide angiotensin II receptor antagonist are presented. The parent diacid analog, SK&F 108566 or (E)-3-

  详细描述了非肽血管紧张素II受体拮抗剂的咪唑5-丙烯酸系列的进一步发展（关于第1部分，请参阅：J。Med。Chem。1992，35，3858）。为了模拟血管紧张素II的Tyr4残基，进行了N-苄基环取代的修饰。在N-苄基环上引入对羧酸导致发现了对受体具有纳摩尔摩尔亲和力和良好口服活性的化合物。这些有效拮抗剂的SAR研究表明，除了两个酸性基团以外，噻吩基环，（E）-丙烯酸和咪唑环对于高效力也很重要。另外，提出了母体二酸与血管紧张素II和代表性的联苯基四唑非肽血管紧张素II受体拮抗剂的叠加比较。母体二酸类似物SK＆
• Non-metallocene compounds, method for the production thereof and use of the same for the polymerisation of olefins
  申请人：——

  公开号：US20040023940A1

  公开（公告）日：2004-02-05

  The invention relates to a method for producing special transition metal compounds, to novel transition metal compounds and to the use of the same for the polymerisation of olefins.

  这项发明涉及一种生产特殊过渡金属化合物的方法，新型过渡金属化合物以及将其用于烯烃聚合的用途。